Literature DB >> 21150589

Mesenchymal stem cell therapy of intestinal disease: are their effects systemic or localized?

Nicholas A Manieri1, Thaddeus S Stappenbeck.   

Abstract

PURPOSE OF REVIEW: Stem cell therapy for intestinal diseases is an emerging area in clinical gastroenterology. We will review recent literature regarding mesenchymal stem cells, which have been utilized in preclinical models and are now headed for clinical trials in several gastrointestinal diseases including inflammatory bowel disease. RECENT
FINDINGS: Important studies over the last 2 years have made significant inroads into understanding the mechanisms of action of these cell types. The two major competing hypotheses are that mesenchymal stem cells home to areas of injury where they repair based on their stem cell activity or that mesenchymal stem cells act as a source of secreted factors that stimulate repair and inhibit inflammation.
SUMMARY: Mesenchymal stem cells show promise for therapy in a number of intestinal diseases. Further understanding of their mechanism of action should improve our ability to use them therapeutically.

Entities:  

Mesh:

Year:  2011        PMID: 21150589      PMCID: PMC3896124          DOI: 10.1097/MOG.0b013e3283423f20

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  46 in total

1.  Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue.

Authors:  Naghmeh Ahmadian Kia; Ahmad Reza Bahrami; Marzieh Ebrahimi; Maryam M Matin; Zeinab Neshati; Mahmood Rais Almohaddesin; Naser Aghdami; Hamid Reza Bidkhori
Journal:  J Mol Neurosci       Date:  2010-10-12       Impact factor: 3.444

2.  Chondrogenic differentiation and immunological properties of mesenchymal stem cells in collagen type I hydrogel.

Authors:  Tun Yuan; Li Zhang; Li Feng; HongSong Fan; XingDong Zhang
Journal:  Biotechnol Prog       Date:  2010 Nov-Dec

3.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

4.  Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing.

Authors:  Qun-Zhou Zhang; Wen-Ru Su; Shi-Hong Shi; Petra Wilder-Smith; Andy Peng Xiang; Alex Wong; Andrew L Nguyen; Chan Wook Kwon; Anh D Le
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

5.  Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs.

Authors:  Hongbao Liu; Wujun Xue; Guanqun Ge; Xiaohui Luo; Yang Li; Heli Xiang; Xiaoming Ding; Puxun Tian; Xiaohui Tian
Journal:  Biochem Biophys Res Commun       Date:  2010-09-24       Impact factor: 3.575

6.  Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat.

Authors:  Hiroki Tanaka; Yoshiaki Arimura; Takashi Yabana; Akira Goto; Masayo Hosokawa; Kanna Nagaishi; Kentaro Yamashita; Hiroyuki Yamamoto; Yasushi Sasaki; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2010-09-17       Impact factor: 7.527

7.  Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon.

Authors:  M Brittan; T Hunt; R Jeffery; R Poulsom; S J Forbes; K Hodivala-Dilke; J Goldman; M R Alison; N A Wright
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

8.  Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.

Authors:  Francesca Schena; Claudio Gambini; Andrea Gregorio; Manuela Mosconi; Daniele Reverberi; Marco Gattorno; Simona Casazza; Antonio Uccelli; Lorenzo Moretta; Alberto Martini; Elisabetta Traggiai
Journal:  Arthritis Rheum       Date:  2010-09

9.  Bone marrow mesenchymal stem cells reduce intestinal ischemia/reperfusion injuries in rats.

Authors:  Haitao Jiang; Linlin Qu; Yun Li; Lili Gu; Yichao Shi; Jian Zhang; Weiming Zhu; Jieshou Li
Journal:  J Surg Res       Date:  2009-08-22       Impact factor: 2.192

Review 10.  Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).

Authors:  Darwin J Prockop; Daniel J Kota; Nikolay Bazhanov; Roxanne L Reger
Journal:  J Cell Mol Med       Date:  2010-09       Impact factor: 5.310

View more
  7 in total

1.  Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice.

Authors:  Nicholas A Manieri; Monica R Drylewicz; Hiroyuki Miyoshi; Thaddeus S Stappenbeck
Journal:  Gastroenterology       Date:  2012-03-27       Impact factor: 22.682

2.  Mesenchymal stem cell treatment for enteric neuropathy in the Winnie mouse model of spontaneous chronic colitis.

Authors:  Ainsley M Robinson; Rhian Stavely; Sarah Miller; Rajaraman Eri; Kulmira Nurgali
Journal:  Cell Tissue Res       Date:  2022-05-10       Impact factor: 5.249

Review 3.  The progress of early growth response factor 1 and leukemia.

Authors:  Jing Tian; Ziwei Li; Yang Han; Tao Jiang; Xiaoming Song; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2016-05

4.  Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis.

Authors:  Nicholas A Manieri; Madison R Mack; Molly D Himmelrich; Daniel L Worthley; Elaine M Hanson; Lars Eckmann; Timothy C Wang; Thaddeus S Stappenbeck
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

Review 5.  Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.

Authors:  Giovanni Dothel; Emanuel Raschi; Roberto Rimondini; Fabrizio De Ponti
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

Review 6.  Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal.

Authors:  Rana Yadak; Marjolein Breur; Marianna Bugiani
Journal:  Orphanet J Rare Dis       Date:  2019-02-08       Impact factor: 4.123

7.  MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing.

Authors:  Xiaoning He; Zhiwei Dong; Yina Cao; Han Wang; Shiyu Liu; Li Liao; Yan Jin; Lin Yuan; Bei Li
Journal:  Stem Cells Int       Date:  2019-09-09       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.